Mitral valve prolapse

Lancet

Volumn 365, Issue 9458, 2005, Pages 507-518

  Hayek, Emil ^a   Gring, Christian N ^b   Griffin, Brian P ^b  

^a Akron General Hospital   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIBIOTIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENZYME INHIBITOR; VASODILATOR AGENT;

ANTIBIOTIC PROPHYLAXIS; BACTERIAL ENDOCARDITIS; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CONFERENCE PAPER; DISEASE EXACERBATION; ELECTROCARDIOGRAM; GENETICS; HIGH RISK POPULATION; HUMAN; MITRAL VALVE PROLAPSE; MITRAL VALVE REGURGITATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; SUDDEN DEATH; SURGICAL RISK; SURGICAL TECHNIQUE; SYMPTOMATOLOGY; UNITED STATES;

EID: 13444302614     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)70275-0     Document Type: Conference Paper

References (150)

1. Barlow JB, Bosman CK. Aneurysmal protrusion of the posterior leaflet of the mitral valve. An auscultatory-electrocardiographic syndrome. Am Heart J. 71:1966;166-178
2. Criley JM, Lewis KB, Humphries JO, Ross RS. Prolapse of the mitral valve: clinical and cine-angiocardiographic findings. Br Heart J. 28:1966;488-496
3. Olson LJ, Subramanian R, Ackermann DM, Orszulak TA, Edwards WD. Surgical pathology of the mitral valve: a study of 712 cases spanning 21 years. Mayo Clin Proc. 62:1987;22-34
4. Waller BF, Morrow AG, Maron BJ, et al. Etiology of clinically isolated, severe, chronic, pure mitral regurgitation: analysis of 97 patients over 30 years of age having mitral valve replacement. Am Heart J. 104:1982;276-288
5. Warth DC, King ME, Cohen JM, Tesoriero VL, Marcus E, Weyman AE. Prevalence of mitral valve prolapse in normal children. J Am Coll Cardiol. 5:1985;1173-1177
6. Levine RA, Triulzi MO, Harrigan P, Weyman AE. The relationship of mitral annular shape to the diagnosis of mitral valve prolapse. Circulation. 75:1987;756-767
7. Levine RA, Stathogiannis E, Newell JB, Harrigan P, Weyman AE. Reconsideration of echocardiographic standards for mitral valve prolapse: lack of association between leaflet displacement isolated to the apical four chamber view and independent echocardiographic evidence of abnormality. J Am Coll Cardiol. 11:1988;1010-1019
8. Levine RA, Handschumacher MD, Sanfilippo AJ, et al. Three-dimensional echocardiographic reconstruction of the mitral valve, with implications for the diagnosis of mitral valve prolapse. Circulation. 80:1989;589-598
9. Freed LA, Levy D, Levine RA, et al. Prevalence and clinical outcome of mitral-valve prolapse. N Engl J Med. 341:1999;1-7
10. Marks AR, Choong CY, Sanfilippo AJ, Ferre M, Weyman AE. Identification of high-risk and low-risk subgroups of patients with mitral-valve prolapse. N Engl J Med. 320:1989;1031-1036
11. Nishimura RA, McGoon MD, Shub C, Miller FA Jr, Ilstrup DM, Tajik AJ. Echocardiographically documented mitral-valve prolapse. Long-term follow-up of 237 patients. N Engl J Med. 313:1985;1305-1309
12. Guthrie RB, Edwards JE. Pathology of the myxomatous mitral value. Nature, secondary changes and complications. Minn Med. 59:1976;637-647
13. Davies MJ, Moore BP, Braimbridge MV. The floppy mitral valve. Study of incidence, pathology, and complications in surgical, necropsy, and forensic material. Br Heart J. 40:1978;468-481
14. Agozzino L, Falco A, de Vivo F, et al. Surgical pathology of the mitral valve: gross and histological study of 1288 surgically excised valves. Int J Cardiol. 37:1992;79-89
15. King BD, Clark MA, Baba N, Kilman JW, Wooley CF. "Myxomatous" mitral valves: collagen dissolution as the primary defect. Circulation. 66:1982;288-296
16. Olsen EG, Al-Rufaie HK. The floppy mitral valve. Study on pathogenesis. Br Heart J. 44:1980;674-683
17. Fornes P, Heudes D, Fuzellier JF, Tixier D, Bruneval P, Carpentier A. Correlation between clinical and histologic patterns of degenerative mitral valve insufficiency: a histomorphometric study of 130 excised segments. Cardiovasc Pathol. 8:1999;81-92
18. Akhtar S, Meek KM, James V. Ultrastructure abnormalities in proteoglycans, collagen fibrils, and elastic fibers in normal and myxomatous mitral valve chordae tendineae. Cardiovasc Pathol. 8:1999;191-201
19. Tamura K, Fukuda Y, Ishizaki M, Masuda Y, Yamanaka N, Ferrans VJ. Abnormalities in elastic fibers and other connective-tissue components of floppy mitral valve. Am Heart J. 129:1995;1149-1158
20. Rabkin E, Aikawa M, Stone JR, Fukumoto Y, Libby P, Schoen FJ. Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodeling in myxomatous heart valves. Circulation. 104:2001;2525-2532
21. Grande-Allen KJ, Griffin BP, Calabro A, Ratliff NB, Cosgrove DM 3rd, Vesely I. Myxomatous mitral valve chordae. II: Selective elevation of glycosaminoglycan content. J Heart Valve Dis 2001; 10: 325-33.
22. Barber JE, Kasper FK, Ratliff NB, Cosgrove DM, Griffin BP, Vesely I. Mechanical properties of myxomatous mitral valves. J Thorac Cardiovasc Surg. 122:2001;955-962
23. Barber JE, Ratliff NB, Cosgrove DM 3rd, Griffin BP, Vesely I. Myxomatous mitral valve chordae. I: mechanical properties. J Heart Valve Dis 2001; 10: 320-24.
24. Mills WR, Barber JE, Skiles JA, et al. Clinical, echocardiographic, and biomechanical differences in mitral valve prolapse affecting one or both leaflets. Am J Cardiol. 89:2002;1394-1399
25. Lax D, Eicher M, Goldberg SJ. Mild dehydration induces echocardiographic signs of mitral valve prolapse in healthy females with prior normal cardiac findings. Am Heart J. 124:1992;1533-1540
26. Levy D, Savage D. Prevalence and clinical features of mitral valve prolapse. Am Heart J. 113:1987;1281-1290
27. Flack JM, Kvasnicka JH, Gardin JM, Gidding SS, Manolio TA, Jacobs DR. Jr. Anthropometric and physiologic correlates of mitral valve prolapse in a biethnic cohort of young adults: the CARDIA study. Am Heart J. 138:1999;486-492
28. Ballester M, Presbitero P, Foale R, Rickards A, McDonald L. Prolapse of the mitral valve in secundum atrial septal defect: a functional mechanism. Eur Heart J. 4:1983;472-476
29. Kambe T, Ichimiya S, Toguchi M, Hibi N, Fukui Y, Nishimura K. Cross-sectional echocardiographic study on the mitral valve prolapse associated with secundum atrial septal defect: pre- and post-operative comparison. Jpn Circ J. 45:1981;260-267
30. Schreiber TL, Feigenbaum H, Weyman AE. Effect of atrial septal defect repair on left ventricular geometry and degree of mitral valve prolapse. Circulation. 61:1980;888-896
31. Suchon E, Podolec P, Plazak W, et al. Mitral valve prolapse associated with ostium secundum atrial septal defect - a functional disorder. Acta Cardiol. 59:2004;237-238
32. Pyeritz RE, McKusick VA. The Marfan syndrome: diagnosis and management. N Engl J Med. 300:1979;772-777
33. Lebwohl MG, Distefano D, Prioleau PG, Uram M, Yannuzzi LA, Fleischmajer R. Pseudoxanthoma elasticum and mitral-valve prolapse. N Engl J Med. 307:1982;228-231
34. Hirata K, Triposkiadis F, Sparks E, Bowen J, Boudoulas H, Wooley CF. The Marfan syndrome: cardiovascular physical findings and diagnostic correlates. Am Heart J. 123:1992;743-752
35. Leier CV, Call TD, Fulkerson PK, Wooley CF. The spectrum of cardiac defects in the Ehlers-Danlos syndrome, types I and III. Ann Intern Med. 92:1980;171-178
36. Lima SD, Lima JA, Pyeritz RE, Weiss JL. Relation of mitral valve prolapse to left ventricular size in Marfan's syndrome. Am J Cardiol. 55:1985;739-743
37. Dolan AL, Mishra MB, Chambers JB, Grahame R. Clinical and echocardiographic survey of the Ehlers-Danlos syndrome. Br J Rheumatol. 36:1997;459-462
38. Jaffe AS, Geltman EM, Rodey GE, Uitto J. Mitral valve prolapse: a consistent manifestation of type IV Ehlers-Danlos syndrome. The pathogenetic role of the abnormal production of type III collagen. Circulation. 64:1981;121-125
39. Shappell SD, Marshall CE, Brown RE, Bruce TA. Sudden death and the familial occurrence of mid-systolic click, late systolic murmur syndrome. Circulation. 48:1973;1128-1134
40. Weiss AN, Mimbs JW, Ludbrook PA, Sobel BE. Echocardiographic detection of mitral valve prolapse. Exclusion of false positive diagnosis and determination of inheritance. Circulation. 52:1975;1091-1096
41. Strahan NV, Murphy EA, Fortuin NJ, Come PC, Humphries JO. Inheritance of the mitral valve prolapse syndrome. Discussion of a three-dimensional penetrance model. Am J Med. 74:1983;967-972
42. Devereux RB, Brown WT, Kramer-Fox R, Sachs I. Inheritance of mitral valve prolapse: effect of age and sex on gene expression. Ann Intern Med. 97:1982;826-832
43. Disse S, Abergel E, Berrebi A, et al. Mapping of a first locus for autosomal dominant myxomatous mitral-valve prolapse to chromosome 16p11.2-p12.1. Am J Hum Genet. 65:1999;1242-1251
44. Freed LA, Acierno JS Jr, Dai D, et al. A locus for autosomal dominant mitral valve prolapse on chromosome 11p15.4. Am J Hum Genet. 72:2003;1551-1559
45. Glesby MJ, Pyeritz RE. Association of mitral valve prolapse and systemic abnormalities of connective tissue. A phenotypic continuum. JAMA. 262:1989;523-528
46. Henney AM, Tsipouras P, Schwartz RC, Child AH, Devereux RB, Leech GJ. Genetic evidence that mutations in the COL1A1, COL1A2, COL3A1, or COL5A2 collagen genes are not responsible for mitral valve prolapse. Br Heart J. 61:1989;292-299
47. Wordsworth P, Ogilvie D, Akhras F, Jackson G, Sykes B. Genetic segregation analysis of familial mitral valve prolapse shows no linkage to fibrillar collagen genes. Br Heart J. 61:1989;300-306
48. Chou HT, Hung JS, Chen YT, Wu JY, Tsai FJ. Association between COL3A1 collagen gene exon 31 polymorphism and risk of floppy mitral valve/mitral valve prolapse. Int J Cardiol. 95:2004;299-305
49. Nasuti JF, Zhang PJ, Feldman MD, et al. Fibrillin and other matrix proteins in mitral valve prolapse syndrome. Ann Thorac Surg. 77:2004;532-536
50. Nascimento R, Freitas A, Teixeira F, et al. Is mitral valve prolapse a congenital or acquired disease? Am J Cardiol. 79:1997;226-227
51. Weis AJ, Salcedo EE, Stewart WJ, Lever HM, Klein AL, Thomas JD. Anatomic explanation of mobile systolic clicks: implications for the clinical and echocardiographic diagnosis of mitral valve prolapse. Am Heart J. 129:1995;314-320
52. ACC/AHA guidelines for the management of patients with valvular heart disease. A report of the American College of Cardiology/American Heart Association. Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). J Am Coll Cardiol. 32:1998;1486-1588
53. Zuppiroli A, Rinaldi M, Kramer-Fox R, Favilli S, Roman MJ, Devereux RB. Natural history of mitral valve prolapse. Am J Cardiol. 75:1995;1028-1032
54. Zuppiroli A, Roman MJ, O'Grady M, Devereux RB. A family study of anterior mitral leaflet thickness and mitral valve prolapse. Am J Cardiol. 82:1998;823-826
55. Cheitlin MD, Armstrong WF, Aurigemma GP, et al. ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography - summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). J Am Coll Cardiol. 42:2003;954-970
56. Carpentier A. Cardiac valve surgery - the "French correction" J Thorac Cardiovasc Surg. 86:1983;323-337
57. Foster GP, Isselbacher EM, Rose GA, Torchiana DF, Akins CW, Picard MH. Accurate localization of mitral regurgitant defects using multiplane transesophageal echocardiography. Ann Thorac Surg. 65:1998;1025-1031
58. Agricola E, Oppizzi M, De Bonis M, et al. Multiplane transesophageal echocardiography performed according to the guidelines of the American Society of Echocardiography in patients with mitral valve prolapse, flail, and endocarditis: diagnostic accuracy in the identification of mitral regurgitant defects by correlation with surgical findings. J Am Soc Echocardiogr. 16:2003;61-66
59. Omran AS, Woo A, David TE, Feindel CM, Rakowski H, Siu SC. Intraoperative transesophageal echocardiography accurately predicts mitral valve anatomy and suitability for repair. J Am Soc Echocardiogr. 15:2002;950-957
60. Devereux RB, Kramer-Fox R, Brown WT, et al. Relation between clinical features of the mitral prolapse syndrome and echocardiographically documented mitral valve prolapse. J Am Coll Cardiol. 8:1986;763-772
61. Savage DD, Devereux RB, Garrison RJ, et al. Mitral valve prolapse in the general population. 2. Clinical features: the Framingham Study. Am Heart J. 106:1983;577-581
62. Pratt CM, Francis MJ, Divine GW, Young JB. Exercise testing in women with chest pain. Are there additional exercise characteristics that predict true positive test results? Chest. 95:1989;139-144
63. Leung DY, Dawson IG, Thomas JD, Marwick TH. Accuracy and cost-effectiveness of exercise echocardiography for detection of coronary artery disease in patients with mitral valve prolapse. Am Heart J. 134:1997;1052-1057
64. Ozkan M, Kaymaz C, Dinckal H, et al. Single-photon emission computed tomographic myocardial perfusion imaging in patients with mitral valve prolapse. Am J Cardiol. 85:2000;516-518
65. Greenspan M, Iskandrian AS, Mintz GS, et al. Exercise myocardial scintigraphy with 201-thallium. Use in patients with mitral valve prolapse without associated coronary artery disease. Chest. 77:1980;47-52
66. Wu TC, Chen JW, Hsu NW, et al. Coronary flow reserve and ischemic-like electrocardiogram in patients with symptomatic mitral valve prolapse. Jpn Heart J. 40:1999;571-578
67. Tentolouris C, Petropoulakis P, Kyriakidis M, et al. Normal coronary flow reserve in patients with mitral valve prolapse, a positive exercise test and normal coronary arteries. Eur Heart J. 16:1995;1960-1967
68. Pasternac A, Tubau JF, Puddu PE, Krol RB, de Champlain J. Increased plasma catecholamine levels in patients with symptomatic mitral valve prolapse. Am J Med. 73:1982;783-790
69. Gaffney FA, Karlsson ES, Campbell W, et al. Autonomic dysfunction in women with mitral valve prolapse syndrome. Circulation. 59:1979;894-901
70. Gaffney FA, Bastian BC, Lane LB, et al. Abnormal cardiovascular regulation in the mitral valve prolapse syndrome. Am J Cardiol. 52:1983;316-320
71. Anwar A, Kohn SR, Dunn JF, et al. Altered beta adrenergic receptor function in subjects with symptomatic mitral valve prolapse. Am J Med Sci. 302:1991;89-97
72. Szombathy T, Janoskuti L, Szalai C, et al. Angiotensin II type 1 receptor gene polymorphism and mitral valve prolapse syndrome. Am Heart J. 139:2000;101-105
73. Chesler E, Weir EK, Braatz GA, Francis GS. Normal catecholamine and hemodynamic responses to orthostatic tilt in subjects with mitral valve prolapse. Correlation with psychologic testing. Am J Med. 78:1985;754-760
74. Lenders JW, Fast JH, Blankers J, de Boo T, Lemmens WA, Thien T. Normal sympathetic neural activity in patients with mitral valve prolapse. Clin Cardiol. 9:1986;177-182
75. Devereux RB, Hawkins I, Kramer-Fox R, et al. Complications of mitral valve prolapse. Disproportionate occurrence in men and older patients. Am J Med. 81:1986;751-758
76. Freed LA, Benjamin EJ, Levy D, et al. Mitral valve prolapse in the general population: the benign nature of echocardiographic features in the Framingham Heart Study. J Am Coll Cardiol. 40:2002;1298-1304
77. Avierinos JF, Gersh BJ, Melton LJ 3rd, et al. Natural history of asymptomatic mitral valve prolapse in the community. Circulation 2002; 106: 1355-61.
78. Mills P, Rose J, Hollingsworth J, Amara I, Craige E. Long-term prognosis of mitral-valve prolapse. N Engl J Med. 297:1977;13-18
79. Stoddard MF, Prince CR, Dillon S, Longaker RA, Morris GT, Liddell NE. Exercise-induced mitral regurgitation is a predictor of morbid events in subjects with mitral valve prolapse. J Am Coll Cardiol. 25:1995;693-699
80. Clemens JD, Horwitz RI, Jaffe CC, Feinstein AR, Stanton BF. A controlled evaluation of the risk of bacterial endocarditis in persons with mitral-valve prolapse. N Engl J Med. 307:1982;776-781
81. MacMahon SW, Roberts JK, Kramer-Fox R, Zucker DM, Roberts RB, Devereux RB. Mitral valve prolapse and infective endocarditis. Am Heart J. 113:1987;1291-1298
82. MacMahon SW, Hickey AJ, Wilcken DE, Wittes JT, Feneley MP, Hickie JB. Risk of infective endocarditis in mitral valve prolapse with and without precordial systolic murmurs. Am J Cardiol. 59:1987;105-108
83. Steckelberg JM, Wilson WR. Risk factors for infective endocarditis. Infect Dis Clin North Am. 7:1993;9-19
84. Devereux RB, Frary CJ, Kramer-Fox R, Roberts RB, Ruchlin HS. Cost-effectiveness of infective endocarditis prophylaxis for mitral valve prolapse with or without a mitral regurgitant murmur. Am J Cardiol. 74:1994;1024-1029
85. Frary CJ, Devereux RB, Kramer-Fox R, Roberts RB, Ruchlin HS. Clinical and health care cost consequences of infective endocarditis in mitral valve prolapse. Am J Cardiol. 73:1994;263-267
86. Dajani AS, Taubert KA, Wilson W, et al. Prevention of bacterial endocarditis: recommendations by the American Heart Association. J Am Dent Assoc. 128:1997;1142-1151
87. Chesler E, King RA, Edwards JE. The myxomatous mitral valve and sudden death. Circulation. 67:1983;632-639
88. Pocock WA, Bosman CK, Chesler E, Barlow JB, Edwards JE. Sudden death in primary mitral valve prolapse. Am Heart J. 107:1984;378-382
89. Kligfield P, Levy D, Devereux RB, Savage DD. Arrhythmias and sudden death in mitral valve prolapse. Am Heart J. 113:1987;1298-1307
90. Grigioni F, Enriquez-Sarano M, Ling LH, et al. Sudden death in mitral regurgitation due to flail leaflet. J Am Coll Cardiol. 34:1999;2078-2085
91. Ciancamerla F, Paglia I, Catuzzo B, Morello M, Mangiardi L. Sudden death in mitral valve prolapse and severe mitral regurgitation. Is chordal rupture an indication to early surgery? J Cardiovasc Surg (Torino). 44:2003;283-286
92. Ling LH, Enriquez-Sarano M, Seward JB, et al. Early surgery in patients with mitral regurgitation due to flail leaflets: a long-term outcome study. Circulation. 96:1997;1819-1825
93. Kramer HM, Kligfield P, Devereux RB, Savage DD, Kramer-Fox R. Arrhythmias in mitral valve prolapse. Effect of selection bias. Arch Intern Med. 144:1984;2360-2364
94. Savage DD, Levy D, Garrison RJ, et al. Mitral valve prolapse in the general population. 3. Dysrhythmias: the Framingham Study. Am Heart J. 106:1983;582-586
95. Kligfield P, Hochreiter C, Kramer H, et al. Complex arrhythmias in mitral regurgitation with and without mitral valve prolapse: contrast to arrhythmias in mitral valve prolapse without mitral regurgitation. Am J Cardiol. 55:1985;1545-1549
96. Martinez-Rubio A, Schwammenthal Y, Schwammenthal E, et al. Patients with valvular heart disease presenting with sustained ventricular tachyarrhythmias or syncope: results of programmed ventricular stimulation and long-term follow-up. Circulation. 96:1997;500-508
97. Tieleman RG, Crijns HJ, Wiesfeld AC, Posma J, Hamer HP, Lie KI. Increased dispersion of refractoriness in the absence of QT prolongation in patients with mitral valve prolapse and ventricular arrhythmias. Br Heart J. 73:1995;37-40
98. Ulgen MS, Biyik I, Karadede A, Temamogullari AV, Alan S, Toprak N. Relation between QT dispersion and ventricular arrhythmias in uncomplicated isolated mitral valve prolapse. Jpn Circ J. 63:1999;929-933
99. Kulan K, Komsuoglu B, Tuncer C, Kulan C. Significance of QT dispersion on ventricular arrhythmias in mitral valve prolapse. Int J Cardiol. 54:1996;251-257
100. Barnett HJ, Boughner DR, Taylor DW, Cooper PE, Kostuk WJ, Nichol PM. Further evidence relating mitral-valve prolapse to cerebral ischemic events. N Engl J Med. 302:1980;139-144
101. Sandok BA, Giuliani ER. Cerebral ischemic events in patients with mitral valve prolapse. Stroke. 13:1982;448-450
102. Scharf RE, Hennerici M, Bluschke V, Lueck J, Kladetzky RG. Cerebral ischemia in young patients: it is associated with mitral valve prolapse and abnormal platelet activity in vivo? Stroke. 13:1982;454-458
103. Kostuk WJ, Boughner DR, Barnett HJ, Silver MD. Strokes: a complication of mitral-leaflet prolapse? Lancet. 2:1977;313-316
104. Davidsen B, Egeblad H, Pietersen A. Thromboembolism in patients with advanced mitral valve prolapse. J Intern Med. 226:1989;433-436
105. Walsh PN, Kansu TA, Corbett JJ, Savion PJ, Goldburgh WP, Schatz NJ. Platelets, thromboembolism and mitral valve prolapse. Circulation. 63:1981;552-559
106. Tse HF, Lau CP, Cheng G. Relation between mitral regurgitation and platelet activation. J Am Coll Cardiol. 30:1997;1813-1818
107. Lin SL, Fisher MJ, Tak T, Rahimtoola SH, Chandraratna PA. Platelet activation in patients with mitral valve prolapse. Can J Cardiol. 5:1989;84-86
108. Fisher M, Weiner B, Ockene IS, Forsberg A, Duffy CP, Levine PH. Platelet activation and mitral valve prolapse. Neurology. 33:1983;384-386
109. Arocha F, Diez-Ewald M, Durango AI, Sulbaran T. Platelet activity in mitral valve prolapse: a study of platelet aggregation, malondialdehyde production, and plasma beta-thromboglobulin. Am J Hematol. 19:1985;21-25
110. Martini F, Zuppiroli A, Gori A, et al. Platelet and blood clotting activation in patients with mitral valve prolapse. Thromb Res. 83:1996;299-306
111. Orencia AJ, Petty GW, Khandheria BK, et al. Risk of stroke with mitral valve prolapse in population-based cohort study. Stroke. 26:1995;7-13
112. Gilon D, Buonanno FS, Joffe MM, et al. Lack of evidence of an association between mitral-valve prolapse and stroke in young patients. N Engl J Med. 341:1999;8-13
113. Avierinos JF, Brown RD, Foley DA, et al. Cerebral ischemic events after diagnosis of mitral valve prolapse: a community-based study of incidence and predictive factors. Stroke. 34:2003;1339-1344
114. Petty GW, Orencia AJ, Khandheria BK, Whisnant JP. A population-based study of stroke in the setting of mitral valve prolapse: risk factors and infarct subtype classification. Mayo Clin Proc. 69:1994;632-634
115. Bonow RO, Carabello B, de Leon AC, et al. ACC/AHA Guidelines for the Management of Patients With Valvular Heart Disease. Executive Summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Valvular Heart Disease). J Heart Valve Dis. 7:1998;672-707
116. David TE, Omran A, Armstrong S, Sun Z, Ivanov J. Long-term results of mitral valve repair for myxomatous disease with and without chordal replacement with expanded polytetrafluoroethylene sutures. J Thorac Cardiovasc Surg. 115:1998;1279-1286
117. Singh RG, Cappucci R, Kramer-Fox R, et al. Severe mitral regurgitation due to mitral valve prolapse: risk factors for development, progression, and need for mitral valve surgery. Am J Cardiol. 85:2000;193-198
118. Wilcken DE, Hickey AJ. Lifetime risk for patients with mitral valve prolapse of developing severe valve regurgitation requiring surgery. Circulation. 78:1988;10-14
119. Kolibash AJ Jr, Kilman JW, Bush CA, Ryan JM, Fontana ME, Wooley CF. Evidence for progression from mild to severe mitral regurgitation in mitral valve prolapse. Am J Cardiol. 58:1986;762-767
120. Fukuda N, Oki T, Iuchi A, et al. Predisposing factors for severe mitral regurgitation in idiopathic mitral valve prolapse. Am J Cardiol. 76:1995;503-507
121. Kizilbash AM, Willett DL, Brickner ME, Heinle SK, Grayburn PA. Effects of afterload reduction on vena contracta width in mitral regurgitation. J Am Coll Cardiol. 32:1998;427-431
122. Host U, Kelbaek H, Hildebrandt P, Skagen K, Aldershvile J. Effect of ramipril on mitral regurgitation secondary to mitral valve prolapse. Am J Cardiol. 80:1997;655-658
123. Tischler MD, Rowan M, LeWinter MM. Effect of enalapril therapy on left ventricular mass and volumes in asymptomatic chronic, severe mitral regurgitation secondary to mitral valve prolapse. Am J Cardiol. 82:1998;242-245
124. Perry GJ, Wei CC, Hankes GH, et al. Angiotensin II receptor blockade does not improve left ventricular function and remodeling in subacute mitral regurgitation in the dog. J Am Coll Cardiol. 39:2002;1374-1379
125. Devlin WH, Starling MR. Outcome of valvular heart disease with vasodilator therapy. Compr Ther. 20:1994;569-574
126. Grayburn PA. Vasodilator therapy for chronic aortic and mitral regurgitation. Am J Med Sci. 320:2000;202-208
127. Akins CW, Hilgenberg AD, Buckley MJ, et al. Mitral valve reconstruction versus replacement for degenerative or ischemic mitral regurgitation. Ann Thorac Surg. 58:1994;668-676
128. Enriquez-Sarano M, Schaff HV, Orszulak TA, Tajik AJ, Bailey KR, Frye RL. Valve repair improves the outcome of surgery for mitral regurgitation. A multivariate analysis. Circulation. 91:1995;1022-1028
129. Wisenbaugh T. Unexpected, dismal left ventricular function after surgery for mitral regurgitation: there is just no excuse for it anymore. J Am Coll Cardiol. 42:2003;464-465
130. Enriquez-Sarano M, Tajik AJ, Schaff HV, et al. Echocardiographic prediction of left ventricular function after correction of mitral regurgitation: results and clinical implications. J Am Coll Cardiol. 24:1994;1536-1543
131. Otto CM. Timing of surgery in mitral regurgitation. Heart. 89:2003;100-105
132. Flemming MA, Oral H, Rothman ED, Briesmiester K, Petrusha JA, Starling MR. Echocardiographic markers for mitral valve surgery to preserve left ventricular performance in mitral regurgitation. Am Heart J. 140:2000;476-482
133. Matsumura T, Ohtaki E, Tanaka K, et al. Echocardiographic prediction of left ventricular dysfunction after mitral valve repair for mitral regurgitation as an indicator to decide the optimal timing of repair. J Am Coll Cardiol. 42:2003;458-463
134. Leung DY, Griffin BP, Stewart WJ, Cosgrove DM 3rd, Thomas JD, Marwick TH. Left ventricular function after valve repair for chronic mitral regurgitation: predictive value of preoperative assessment of contractile reserve by exercise echocardiography. J Am Coll Cardiol 1996; 28: 1198-205.
135. Agricola E, Galderisi M, Oppizzi M, et al. Pulsed tissue Doppler imaging detects early myocardial dysfunction in asymptomatic patients with severe mitral regurgitation. Heart. 90:2004;406-410
136. Pellerin D, Sharma R, Elliott P, Veyrat C. Tissue Doppler, strain, and strain rate echocardiography for the assessment of left and right systolic ventricular function. Heart 2003; 89 (suppl 3): iii9-17.
137. Ling LH, Enriquez-Sarano M, Seward JB, et al. Clinical outcome of mitral regurgitation due to flail leaflet. N Engl J Med. 335:1996;1417-1423
138. Stewart WJ, Currie PJ, Salcedo EE, et al. Evaluation of mitral leaflet motion by echocardiography and jet direction by Doppler color flow mapping to determine the mechanisms of mitral regurgitation. J Am Coll Cardiol. 20:1992;1353-1361
139. Gillinov AM, Cosgrove DM, Blackstone EH, et al. Durability of mitral valve repair for degenerative disease. J Thorac Cardiovasc Surg. 116:1998;734-743
140. David TE, Ivanov J, Armstrong S, Rakowski H. Late outcomes of mitral valve repair for floppy valves: Implications for asymptomatic patients. J Thorac Cardiovasc Surg. 125:2003;1143-1152
141. Stewart WJ. Choosing the "golden moment" for mitral valve repair. J Am Coll Cardiol. 24:1994;1544-1546
142. Gillinov AM, Cosgrove DM 3rd. Modified sliding leaflet technique for repair of the mitral valve. Ann Thorac Surg 1999; 68: 2356-57.
143. Gillinov AM, Cosgrove DM 3rd, Shiota T, et al. Cosgrove-Edwards Annuloplasty System: midterm results. Ann Thorac Surg 2000; 69: 717-21.
144. Cohn LH, Couper GS, Aranki SF, Rizzo RJ, Kinchla NM, Collins JJ Jr. Long-term results of mitral valve reconstruction for regurgitation of the myxomatous mitral valve. J Thorac Cardiovasc Surg. 107:1994;143-151
145. Phillips MR, Daly RC, Schaff HV, Dearani JA, Mullany CJ, Orszulak TA. Repair of anterior leaflet mitral valve prolapse: chordal replacement versus chordal shortening. Ann Thorac Surg. 69:2000;25-29
146. Smedira NG, Selman R, Cosgrove DM, et al. Repair of anterior leaflet prolapse: chordal transfer is superior to chordal shortening. J Thorac Cardiovasc Surg. 112:1996;287-292
147. Totaro P, Tulumello E, Fellini P, et al. Mitral valve repair for isolated prolapse of the anterior leaflet: an 11-year follow-up. Eur J Cardiothorac Surg. 15:1999;119-126
148. Gillinov AM, Cosgrove DM 3rd, Wahi S, et al. Is anterior leaflet repair always necessary in repair of bileaflet mitral valve prolapse? Ann Thorac Surg 1999; 68: 820-24.
149. Mohty D, Orszulak TA, Schaff HV, Avierinos JF, Tajik JA, Enriquez-Sarano M. Very long-term survival and durability of mitral valve repair for mitral valve prolapse. Circulation. 104:2001;I1-I7
150. Braunberger E, Deloche A, Berrebi A, et al. Very long-term results (more than 20 years) of valve repair with carpentier's techniques in nonrheumatic mitral valve insufficiency. Circulation. 104:(suppl 1):2001;I8-11